Lysaker

Payment received for sale of Oxenøen

On 9 September, Norske Skog announced that it had sold the Oxenøen property at Lysaker, outside Oslo for NOK 429.5 million to a company owned by Aspelin Ramm and OBOS. The payment for this sale has .. - Read more

Low Vitamin K2 Status is A Risk Factor for Hardening of the Arteries - Presented at the American S..

13 November 2008, Lysaker, Norway -NattoPharma and PL Thomas, announced significant exposure and discussion of Vitamin K2 and its role in promoting cardiovascular health at the American Society of N.. - Read more

Study Demonstrating Lovaza/Omacor Co-administered with Atorvastatin Reduces Non-HDL Cholesterol to..

11 November, 2008, Lysaker, Norway: Pronova BioPharma ASA (OSE: PRON.OL) ("Pronova BioPharma" or the "company") today announces that a study to be presented at the American Heart Association Scienti.. - Read more

Navamedic concentrates key resources on the development of its Vitaflo business

The company will initiate a process to move main head office functions to Gothenburg. Change in top management. - - (Lysaker, Norway) The Board of Directors of Navamedic ASA has decided to focus the co... [WebWire - Monday,...

MANDATORY NOTIFICATION OF TRADE

10 November, 2008, Lysaker, Norway: Primary insider, vice president legal affairs, Cecilia Orheim, has today bought 38 400 shares in the company.The shares were bought at an average share price of N.. - Read more

Pronova BioPharma ASA (NO) - Mandatory NOtification of Trade

Lysaker, Norway, 7 November, 2008 - Primary insiders have today sold a total of 787 500 shares in the company. The shares were sold at an average share price of NOK 19.31. The following primary insiders have sold shares:...

NEAS ASA - Notice of Extraordinary General Meeting

Notice of NEAS` Extra Ordinary General Meeting is enclosed. The meeting will be held at NEAS' headquarter, Granfos Næringspark, Vollsveien 13H, Lysaker (outside Oslo) on 21 November 2008 at 10:00. .. - Read more

Pronova BioPharma announces Strategic Supply Agreement for a Fixed Dose Combination Product with O..

5 November 2008, Lysaker, Norway: Pronova BioPharma ASA PRON.OL) ("Pronova BioPharma" or the "company") today announces that its subsidiary Pronova BioPharma Norge AS has entered into a strategic supply agreement Farmacêutica...

Extraordinary general meeting in Wilh. Wilhelmsen ASA

An extraordinary general meeting in Wilh. Wilhelmsen ASA will be held on Thursday 20 November 2008 at 14.00 at the company`s premises at Strandveien 20, NO-1366 Lysaker. Attached please find the sum.. - Read more